baber/WOPTO huggingface dataset:
Patent JP-2001522337-A (JP)
IPC: A45D40/22
Filed: 1998-02-17
Abstract: A container and sealing closure therefor, includes a container body part having an access opening and includes a continuous peripheral wall surrounding the access opening, and a closure part. The wall of the body part has a peripherally extending continuous sealing edge portion at its upper outer surface, the edge portion being coextensive with the wall. The closure part has a resilient skirt portion. The sealing edge portion of the wall of the container part has a sharp apex forming an included angle of substantially 90 degrees. The skirt portion of the closure part is adapted to mate in spaced relation, with the peripheral wall of the container part and has an inner surface which extends obliquely with respect to the peripheral wall of the body part and which is adapted to engage the apex. There are provided coengaging structural elements on the container body and closure parts, holding the resilient skirt portion of the closure part forcibly against the apex as the closure part is advanced against the container body part to a sealing, closed position thereon.
Patent JP-2000513124-A (JP)
Title: 表示ボードデジタイザシステム
IPC: G06F3/041
Filed: 1998-02-25
Abstract: (57)【要約】
大きなボードのための表示ボードデジタイザシステムでは、少なくとも３つの間隔をおいて設けられた超音波受信器アッセンブリを使うのが好ましい。超音波送信器の現在位置は、少なくとも２対の受信器アッセンブリに基づく飛行時間位置測定値の重み付き重心として割り当てられる。使われる重み付けは、ボードを横切る送信器の位置の関数として変化する。システムで使うための超音波受信器アッセンブリの好適の構造では、表示ボードの表面に垂直な線上に並んで配置された一対の超音波受信器を採用する。受信器は、各々で受信された超音波信号の瞬間合計に一致する総出力信号を生成するように、受信器アッセンブリが表示ボードに近接する平面から入射する超音波信号に最も敏感となるように接続されている。更に、超音波送信器がペンと同軸であり且つその先端に近接している円筒形エレメントである従来型ペンと共に使うための送信器装置、及び連結されたイレーザー構造についても述べられている。
Patent JP-2001516387-A (JP)
Title: 低レベルのポリカルボン酸を使用する単糖及び二糖の重合
IPC: C08B37/00
Filed: 1998-03-19
Abstract: (57)【要約】
優れた品質且つすっきりした味の食品グレードのポリデキストロースは、グルコース又はグルロース含有物質例えば加水分解澱粉とポリオール例えばソルビトールとを低レベルのポリカルボン酸例えばクエン酸の存在下に反応させることにより製造される。一つの態様では、ポリデキストロースは、約１４５−約１８５℃好ましくは約１５０−約１６０℃の温度で約０．０３−約０．１％のクエン酸の存在下で上記の原料を反応させることにより製造される。好ましい態様で使用される触媒の低レベルのため、反応中に形成される悪い味は全くないか又は最低であり、色もほとんど形成されないが、生成物は、イオン交換、膜濾過、又は炭素処理を使用して精製できるか、又はさらに或る使用には所望ならば水素化により変性できる。
Patent JP-2001501775-A (JP)
Title: 電気入力／出力手段を備える改良熱電ユニット
IPC: H01L35/00
Filed: 1997-05-09
Abstract: (57)【要約】
一連の熱電対が、トーラス（６０）を形成するように密充填され、誘電絶縁タイストラプにより圧縮保持され、ローレンツ力に抗する。低熱伝導素子（６４）と、高温フィン（６６）と低温フィン（６５）に形成された溝（３８）が成す短縮電気経路長によりトーラス（６０）を、高電流が還流する。高温フィン（６６）と低温フィン（６５）間の熱伝達が低下して、より高い循環電流が発生される。高・低温フィン（６６、６５）と低熱電導素子（６４）の間に形成される熱電接合を、好ましくはビスマス、コンスタンタン、ニッケル、セレニウム、テルル、シリコン、ゲルマニウム、アンチモン、ニクロム、鉄、カドミウム、タングステン、金、銅、亜鉛及び銀を含む異種材料の被覆層で確立する。熱電発電器（４０）として動作して、振動する機械的スイッチ（７０）、ホール効果発生器（１４０）又はコルピッツ発振器（１５９）の何れかを用い、還流する電流から電力を引き出すことができる。
Patent JP-H10511140-A (JP)
Title: 腐食抑制剤を含むアルキルエーテルアミンコンベヤ潤滑剤
IPC: C10N40/00
Filed: 1997-03-10
Abstract: (57)【要約】
本発明は、潤滑剤濃縮組成物、使用溶液およびその使用方法である。前記潤滑剤は、式Ｒ 1 −Ｏ−Ｒ 2 −ＮＨ 2 、Ｒ 1 −Ｏ−Ｒ 2 −ＮＨ−Ｒ 3 −ＮＨ 2 で表されるアミン化合物またはこれらの混合物、および、腐食抑制剤を含む。但し、Ｒ 1 は直鎖Ｃ 6 −Ｃ 18 アルキルであり、Ｒ 2 は直鎖または分枝Ｃ 1 −Ｃ 8 アルキルであり、Ｒ 3 は直鎖Ｃ 1 −Ｃ 8 アルキルである。潤滑剤組成物は、好ましくは腐食抑制剤としてポリカルボン酸を含む。また、組成物は、ヒドロトロピー剤、安定剤、並びに、希釈および使用時における組成物に洗浄性を付与するための界面活性剤をも含み得る。また、本発明は、この濃縮組成物を希釈して得られる潤滑剤溶液を含むものである。
Patent JP-2002515036-A (JP)
IPC: A61P29/00
Filed: 1997-05-30
Abstract: The present invention describes methods for inhibiting angiogenesis in tissues using vitronectin  alpha v beta 5 antagonists. The  alpha v beta 5-mediated angiogenesis is correlated with exposure to cytokines including vascular endothelial growth factor, transforming growth factor- alpha  and epidermal growth factor. Inhibition of  alpha v beta 5-mediated angiogenesis is particularly preferred in vascular endothelial ocular neovascular diseases, in tumor growth and in inflammatory conditions, using therapeutic compositions containing  alpha v beta 5 antagonists.
Patent JP-2001520710-A (JP)
Title: 染色繊維物の酵素的抜染
IPC: D06L3/02
Filed: 1998-03-26
Abstract: (57)【要約】
オキシドレダクターゼ及び促進剤によって、染色布地、特にセルロース性布地、例えばデニムの表面を酵素的に抜染する方法。
Patent JP-2001522534-A (JP)
Title: ＩｎＡ１ＡｓＳｂ／Ａ１Ｓｂバリヤを備えた電子デバイスの設計および製造
IPC: H01L21/308
Filed: 1998-03-26
Abstract: (57)【要約】
ＧａＡｓ基板（８）と基板上に配置された基部とによって特徴づけられる電子デバイスであって、基部は、ＩｎＡｓチャネル層（１６）と、このチャネル層の上のＡｌＳｂ（１８）層と、ＡｌＳｂチャネル層の上に配置され、少なくともＩｎ、ＡｌおよびＡｓを含むＩｎ x Ａｌ 1-x Ａｓ y Ｓｂ 1-y 層（２０）と、Ｉｎ x Ａｌ 1-x Ａｓ y Ｓｂ 1-y 層の上に配置され、これに接触するＩｎＡｓキャップ層（２２）と、ＩｎＡｓチャネル層の下に配置され、基板に接触するＡｌＳｂ（１４）層と、ＡｌＳｂ層内に配置されるｐ + ＧａＳｂ層（１２）と、Ｉｎ x Ａｌ 1-x Ａｓ y Ｓｂ 1-y 層に接触して配置されるパッドを備えたショットキーゲート（２８）と、ＩｎＡｓキャップ層に配置された少なくとも１つのオーム接触（２４、２６）と、基部を通って基板へ延在してデバイスからゲートボンディングパッドを分離して、ゲートとＩｎＡｓとの間の接触を防ぐゲートエアブリッジを提供するトレンチ（３０）とを具備する電子デバイスが開示される。ゲートエアブリッジ形成は、容積ベースで２分の１以上の凝縮乳酸または酢酸を含み、残りは過酸化水素と凝縮フッ化水素酸である液体エッチング剤によって達成される。エッチング剤は、ＩｎＡｓ、Ｉｎ x Ａｌ 1-x Ａｓ y Ｓｂ 1-y 、ＡｌＳｂおよびＧａＳｂを腐蝕するが、ＧａＡｓおよびＡｕ系合金を腐蝕しない。
Patent JP-2000515720-A (JP)
Title: 電圧変換装置
IPC: H02J1/12
Filed: 1998-04-22
Abstract: (57)【要約】
ここで提供されているのは、例えば自動車に使用されるべき電圧変換装置である。電圧変換を行うために、部分変換器としての複数の小さな電圧変換器が相互に並列に接続されている。個別の部分変換器を順次スイッチングし、出力電流を重畳することによって、平滑な出力電流が、わずかな入力負荷で得られる。
Patent NZ-213177-A (NZ)
Title: Use of flange to secure cover to end of thin - walled tube
Inventor: VAN DER GRAAF M H
IPC: B65G23/08
Filed: 1985-08-21
Abstract: A method of securing a cover (2) to the end of a thin-walled tube (1) using a flange (3). According to the invention the flange (3) is slidably disposed in the tube and is restrained from being pulled out of the tube by a resilient ring (5) accommodated in a shallow groove (4) in the inner wall of the tube (1). The ring (5) is maintained in position by a supporting edge of the cover (2) or, alternatively, by bolts (8) disposed closely to the circumferential edge of the power cover to secure the cover to the flange.
Patent NZ-223180-A (NZ)
Title: Guanidinoacetic and ethanamidinoacetic acid derivatives and sweetening compositions
Inventor: NOFRE C
IPC: A23L27/30
Filed: 1988-01-13
Abstract: Sweetening agents of the formula: <IMAGE> in which, in a preferred embodiment, R0 is: either a heterocyclic ring constructed on a cyclopentadienyl or phenyl group by replacement of 1 to 3 cyclic C with N, O or S, or an indanyl, indenyl, naphthyl or tetrahydronaphthyl group or a heterocyclic derivative constructed on these groups by replacement of 1 to 4 cyclic C with N, O or S; R1 is H or CH3; R2 is a 2-13 C hydrocarbon group in which up to 4 C may be replaced by N, O, S, Cl, Br and I and up to 5 H by F; R3 and R4 are H.
Patent NZ-227273-A (NZ)
Title: Aromatically substituted alkylaminoalkanediphosphonic acid derivatives, preparation thereof and pharmaceutical compositions
Inventor: JAEGGI KNUT ALFRED
IPC: C07F9/547
Filed: 1988-12-09
Abstract: Araliphatylaminoalkanediphosphonic acids of the formula <IMAGE> in which R1 represents an aromatically substituted aliphatic radical, R2 represents hydrogen or a monovalent aliphatic radical and alk denotes a divalent aliphatic radical, and their salts have a marked regulating action on calcium metabolism and can be used as medicaments for the treatment of diseases which can be traced back to disorders thereof. They are prepared, for example, by reacting a compound of the formula <IMAGE> in which X3 denotes carboxyl and R0 denotes a radical R2, with phosphorous acid and phosphorus trichloride and hydrolysing the primary product.
Patent NZ-235333-A (NZ)
Title: Resolution of enantiomers of 5-alkoxy(+)1,3 dimethyloxindolylethylamines
Inventor: LEE THOMAS BING KIN
IPC: C07D209/34
Filed: 1990-09-17
Abstract: A process for chemically resolving a mixture of enantiomers of primary amines, such as enantiomers of 1,3-dimethyl-5-methoxyoxindolylethylamine, provides one of the enantiomers in the form of a tartaric acid salt. In carrying out the process, an enantiomeric mixture is contacted with a chiral acid in an amount sufficient to preferentially precipitate a salt of the chiral acid and one of the enantiomers. The resulting precipitate can then be recovered. The chiral acid is selected from the group consisting of dibenzoyl-D-tartaric acid, dibenzoyl-L-tartaric acid, ditoluoyl-D-tartaric acid, and ditoluoyl-L-tartaric acid. The precipitates can be used in the synthesis of stereospecific forms of physostigmine.
Patent NZ-241164-A (NZ)
Title: Recyclable pallet constructed from paperboard material: pylons secured between upper and lower panels
Inventor: CREWS MITCHELL S
IPC: B65D19/34
Filed: 1991-12-23
Abstract: A substantially recyclable shipping platform apparatus (20) for supporting and transporting loads, in which the apparatus is easily disposable and recyclable after use. A plurality of substantially elongated pylons (26...34) are attached between a top platform (22) and a bottom panel (23) to increase the integrity of the apparatus to more effectively support the load material placed upon the platform. The bottom panel is constructed with articulateable flaps which are used to secure the pylons to the bottom panel. Each of these flaps are configured to maximize contact with, and stability of, the pylons, and are further configured to correspond to the specific shape of the interior region of each respective pylon they are attached to. A tear strip may be embedded within the platform and/or bottom panel for purposes of reducing the overall size of the apparatus when disposal is desired.
Patent NZ-248422-A (NZ)
Title: Use of(dihomo-)gamma-linolenic acid (dgla,gla) or linoleic acid(la) to increase gut calcium absorption in humans
Inventor: HORROBIN DAVID FREDERICK
IPC: A61P43/00
Filed: 1993-08-17
Abstract: Increasing gut calcium absorption in humans or animals by the administration of GLA, DGLA or LA as such or in salt or other pharmacologically acceptable form, optionally in association with EPA, DHA or other EFA in similar forms, specifically useful in the treatment of osteoporosis.
Patent NZ-267489-A (NZ)
Title: Antifungal nail treatment solution
Inventor: BURNETT DEBBIE L
IPC: A61K8/00
Filed: 1994-07-04
Abstract: A composition useful in the treatment of onychomycosis comprises tioconazole, a gel-forming agent and a hydro-alcoholic vehicle.
Patent NZ-278258-A (NZ)
Title: Hygroscopic detergent articles comprising a hydroscopic barrier coating
Inventor: HEILE BERNARD JOSEPH
IPC: C11D3/08
Filed: 1994-12-20
Abstract: There is provided an environmentally stable detergent article. Normally, hygroscopic caustic detergent materials can be made resistant to absorption of ambient humidity or water by introducing a barrier coating onto the caustic detergent. The barrier also renders the highly active alkaline material safe for human handling. The coated detergent article can further be enclosed in a film enclosure or wrapping which provides further protection for handling during production, shipment, storage and final end use. The coated article can be removed from any packaging material, inserted into a water spray-on dispenser and used to create a concentrated aqueous detergent for use in ware washing machines. In order to obtain control over dispensing, hydrophobic coatings can be nicked, split, peeled or partially removed using other means to provide an initial surface of caustic detergent exposed to the water spray. The water spray can then dispense the detergent and either melt or dissolve the hydrophobic coating in a controlled manner.
Patent NZ-306429-A (NZ)
Title: transdermal system containing a matrix of polyisobutane or butyl rubber and an angiotensin converting enzyme inhibitor
Inventor: FISCHER WILFRIED
IPC: A61K9/70
Filed: 1996-03-29
Abstract: The transdermal system has a polyisobutylene or butyl rubber matrix containing ramipril and/or transdolapril as angiotension-coverting enzyme inhibitor (ACE inhibitor).
Patent NZ-318633-A (NZ)
Title: Laminated sealable non-foil packaging material comprising a paperboard substrate
Inventor: MARANO GERALD A
IPC: B32B27/32
Filed: 1996-09-12
Abstract: A non-foil composite structure is provided having a substantial barrier to the loss of moisture, oxygen and organic vapor and which is easily sealable with a shelf-life to at least one year for food and non-food products during dry shelf storage, and which is environmentally friendly. The laminate may have, from the outer atmosphere exposed surface to the inner surface contacting the contents of the container; a first exterior layer of a low density polyethylene polymer 22; a paperboard substrate 20; a first interior layer laminate coating of nylon 24 with a tie layer 26; a first interior layer of high density polyethylene polymer 40; a second interior layer of low density polyethylene polymer 42; and s second interior layer of high density polyethylene polymer 44. <IMAGE>
Patent NZ-332320-A (NZ)
Title: 6-0-substituted erythromycin compounds and medicaments
Inventor: OR YAT SUN
IPC: C07H17/08
Filed: 1997-05-06
Abstract: The erythromycin derivative has one of the formulae II to IX or a pharmaceutically acceptable salt, ester or prodrug thereof wherein: X is =O, =NOH, =NOR1 or =NOC(R5)(R6)-O-R1; Ra and Rb are independently H or OH; one of Rc and Rd is H and the other is OH, protected OH, halogen, NR6R7, OCO-NH-aryl, O-CO-NH-heteroaryl, O-CO-NR7R8, O-SO2-(optionally substituted alkyl) or O-SO2-(CH2)2-NR7R8 or together form =O, =NOH or =NOR1; R3 is methoxy, F or OH; Rf is H or a hydroxy protecting group; W is absent, O, NH-CO, N=CH or NH; Rg is H, cycloalkyl or optionally substituted alkyl, aryl or heteroaryl; Rh is H, OH, O-C(O)-imidazolyl, O-C(O)-O-alkyl, O-C(O)-O-(optionally substituted aryl), O-C(O)-Cl or O-C(O)-NH2; R is substituted methyl or optionally substituted C2-10 alkyl, C3-10 alkenyl or C3-10 alkynyl; one of Y and Z is hydrogen and the other is H, OH, protected OH or NR7R8; A, B, D and E are independently H, cycloalkyl or optionally substituted alkyl, aryl or heteroaryl, heterocycloalkyl or is optionally substituted aryl, heteroaryl, OH, alkoxy, halo or NR9R10 further substituted with MR11 or any of AB, AD, AE, BD, BE or DE together with the atoms to which they are attached form a 3-7 membered ring optionally containing O, NR', S(O)n, C(O)-NH, C(O)-NR12, NH-C(O), NR12-C(O)- or C(=NH)-NH provided that at least two of A, B, D and E are hydrogen and the rest of the variables are defined in the specification. A pharmaceutical composition thereof is useful for treating bacterial infections.
Patent NZ-334982-A (NZ)
Title: A training equipment for sailing athletes has feet holding means and sensing means
Inventor: MERELLO ANDREA
IPC: A63B23/02
Filed: 1997-10-09
Abstract: he training equipment 1 is intended for training athletes in sitting out a sailboat, and comprises a frame 2, a seat 3 pivoted to frame 2 and adjustable in angular position relative to it, means 5 of adjusting the angular position of the seat on the frame, and means 17 of holding the feet of an athlete accommodated on the seat.  Equipment 1 also comprises sensing means 8 which senses the athletes activity.  With this equipment, an athlete can train himself in postures substantially identical with those he would assume under varying conditions during a boat race.
Patent NZ-336194-A (NZ)
Title: Optical fibre with non-linearity coefficient < 2 /W Km and graded refractive index
Inventor: TIRLONI BARTOLOMEO ITALO
IPC: G02B6/036
Filed: 1999-06-10
Abstract: An optical transmission fibre with a high effective area and low non-linearity coefficient ã has glass inner core 12 with a maximum refractive index difference Än1, a profile á and a radius r1.  Surrounding the inner core, is a glass layer 14 with a maximum refractive index difference Än2 less than Än1, and with an outer radius r2.  A second glass layer 16 surrounds layer 14, layer 16 having a maximum refractive index difference Än3 less than Än1 and with a width w.  A low loss cladding 18 surrounds the layer 16.  The absolute value of the refractive index difference Än2 is less than 10% of Än3, and the non-linearity coefficient ã is less than 2 W-1 km-1.
Patent NZ-337669-A (NZ)
Title: Composition containing moisture regulators and a non-ionic surfactant for use in tissue products
Inventor: NEUNHOFFER HANS
IPC: D06M13/342
Filed: 1998-02-10
Abstract: A composition comprises: a) 40 to 90% by weight relative to the total composition of a moisture or humidity regulators for tissue products and b) 1 to 25 % by weight relative to the total composition of at least one nonionic surfactant selected from at least one amine oxide and/or hydroxy acid esters and/or at least one amphoteric surfactant. Also disclosed are tissue products containing the above composition.
Patent NZ-503485-A (NZ)
Title: Aromatic sulfone hydroxamic acid metalloprotease inhibitor
Inventor: MCDONALD JOSEPH J
IPC: A61P9/10
Filed: 1998-11-12
Abstract: A treatment process is disclosed which comprises administering an effective amount of an aromatic sulfone hydroxamic acid that inhibits one or more matrix metalloprotease (MMP) enzymes, such as MMP-2, MMP-9 and MMP-13, while exhibiting less inhibition of MMP-1, to a host having a condition associated with pathological matrix metalloprotease activity.  The administered enzyme inhibitor corresponds in structure to formula (I), below, or a pharmaceutically acceptable salt thereof, wherein R1 and R2 are both hydrido or R1 and R2 together with atoms to which they are bonded form a 5- to 8-membered ring containing one, two or three heteroatoms in the ring that are oxygen, sulfur or nitrogen. R3 in formula (I) is an optionally substituted aryl or optionally substituted heteroaryl radical.  Also disclosed are metalloprotease inhibitor compounds having those selective activities, processes for manufacture of such compounds and pharmaceutical compositions using these inhibitors.
Patent NZ-504493-A (NZ)
Title: Transformer
Inventor: SCHUTTE THROSTEN
IPC: H01F27/32
Filed: 1998-11-30
Abstract: A power transformer comprising at least one high voltage winding (32) and one low voltage winding (30). Each of the windings includes at least one current-carrying conductor, a first layer having semi-conducting properties provided around said conductor, a solid insulating layer provided around said first layer, and a second layer having semi-conducting properties provided around said insulating layer. The windings are intermixed such that turns of the high voltage winding are mixed with turns of the low voltage winding.
Patent NZ-508650-A (NZ)
Title: Regulating hematopoiesis using unmethylated C and G CpG-oligonucleotides with a phosphorothioate modification
Inventor: WAGNER HERMANN
IPC: C12N15/09
Filed: 1999-05-14
Abstract: The use of CpG containing oligonucleotides in the manufacture of a medicament to induce hematopoiesis to treat immune system disorders.  The oligonucleotide may include a phosphorothioate or phosphorothioate modification.  The oligonucleotide is administered at least 3 days prior to exposure to an antigen in order to increase platelet counts in thrombocytopenia sufferers and induce erythropoiesis in anaemia sufferers.
Patent NZ-511424-A (NZ)
Title: Hygromycin A derivatives as antibacterial agents
Inventor: HAYWARD MATTHEW MERRILL
IPC: A61P31/04
Filed: 1999-11-09
Abstract: Compounds of formula 1 and pharmaceutically acceptable salts and solvates thereof, wherein R1, R2, R3, X1 and X2 are as defined herein. The compounds of formula 1 are antibacterial and antiprotozoal agents that may be used to treat various bacterial and protozoal infections and disorders related to such infections. The disclosure also relates to pharmaceutical compositions containing the compounds of formula 1, methods of treating bacterial and protozoal infections by administering the compounds of formula 1, and methods of preparing certain compounds of formula 1.
Patent NZ-513535-A (NZ)
Title: Bicameral scale musical intonations and recordings made therefrom
Inventor: PYE T WILFRED
IPC: G10H1/44
Filed: 2000-01-19
Abstract: This application relates to various stepped pitch instruments crafted to a novel musical tuning system for the generated frequencies. As such, the tone selection devices are arranged to a distinct set of interval specifications when compared to the tone selection devices for a prior art instrument crafted to sound the common frequencies of 12 tone equal temperament. To generate the bicameral tones, the preferred tuning system utilizes two different series of Pythagorean perfect fifths separated by a known reference interval. Relative to 12 tone, the instant tuning system is primarily concerned with improving the sour major and minor thirds and perfecting the slightly flat fifths. Substantially fewer tones per octave are used than the number required by standard just intonation. Various modifications to existing prior art instruments are described, as well as a novel enharmonic multitone keyboard
Patent NZ-514918-A (NZ)
Title: Compositions and methods for cancer treatment by selectively inhibiting VEGF
Inventor: THORPE PHILIP E
IPC: A61K47/48
Filed: 2000-04-28
Abstract: A composition comprising a biologically effective amount of purified anti-VEGF antibody which binds the same epitope as antibody ATCC PTA 1595, and significantly inhibits VEGF binding to VEGF receptor VEGFR2 without significantly inhibiting VEGF binding to VEGF receptor VEGFR1. Use of the composition for inhibiting angiogenesis, treating ocular neovascular disease or macular degeneration and treating cancer is also covered, along with methods of producing said antibody and the use of the composition in a kit.
Patent NZ-516240-A (NZ)
Title: Prion protein peptides and uses thereof
Inventor: CASHMAN NEIL R
IPC: C07K16/00
Filed: 2000-06-23
Abstract: An antibody binds with high binding affinity to a YYX epitope of a mammalian PrPSc. Hybridomas that produce the antibodies and compositions that comprise the antibody are also described. The antibodies can be used in methods for detecting PrPSc in a sample and for decontaminating PrPSc in a sample. Also described is a vaccine for immunizing against a prion disease which comprises a peptide composed of 12 or less amino acids and comprising the sequence selected from YYX, A-YYR, A-YYD, A-YYQ or A-YYRRYYRYY wherein A is either any amino acid or absent, a pharmaceutically acceptable carrier.
Patent NZ-518950-A (NZ)
Title: Dip coating compositions containing cellulose ethers with a gloss value of at least 150 and the coating is devoid of gelatine
Inventor: GULIAN CYNTHIA
IPC: A61K47/38
Filed: 2002-05-14
Abstract: A water soluble composition for dip-coating a substrate comprises: a) hydroxypropylmethyl cellulose and b) a thickener selected from xanthan gum, carrageenan and mixtures thereof or castor oil or maltodextrin The composition possesses a surface gloss of at least 150 when applied via dip coating to a substrate. Also described are pharmaceutical dosage forms comprising a core, and a coating covering the core comprising the water soluble composition described above.
Patent NZ-520887-A (NZ)
Title: Cryogenic re-crystallisation of hard fats resulting in smaller crystals with enhanced properties
Inventor: BROOKER BRIAN EDWARD
IPC: A23D9/00
Filed: 2002-08-20
Abstract: A method of processing the solid fat phase of a food product is described. The method comprises or contains a dispersion of solid fat in an oil phase in which the solid fat phase is brought into contact with a minimal amount of the oil phase in a liquid state. This occurs in a cooling device where the product is cooled to effect fat crystallisation as quickly as possible.
Patent NZ-523464-A (NZ)
Title: Treating inflammatory conditions via compounds that inhibit semicarbazide-sensitive amine oxidases (SSAO)-a class of copper-containing amine oxidases
Inventor: SMITH DAVID JOHN
IPC: A61K31/445
Filed: 2001-07-04
Abstract: Use of hydrazino compounds of the following formulas to treat inflammatory conditions via the inhibition of semicarbazide-sensitive amine oxidases (SSAO).